|
| (E)-N-(6-methylsulfonyl-1,3-benzothiazol-2-yl)-3-[3-[(2-methyl-1,3-thiazol-4-yl)methoxy]phenyl]prop-2-enamide |
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Case HB, et al. 2018. Biochemistry |
|
| Oroxylin A |
|
Staphylococcus |
Others |
Preclinical (in vitro) |
Jiang X, et al. 2023. J Appl Microbiol |
|
| Astilbin |
|
Streptococcus |
Others; Adherence; Biofilm |
Preclinical (in vitro) |
Wang J, et al. 2019. Molecules |
|
| Rutin |
|
Streptococcus |
Others |
Preclinical (in vitro) |
Yang WY, et al. 2016. J Microbiol Biotechnol |
|
| Theaflavine |
|
Streptococcus |
Biofilm |
Preclinical (in vitro) |
Kong J, et al. 2021. AMB Express |
|
| 4-({[2-(3-iodophenyl)-1,3-benzoxazol-5-yl]imino}methyl)-2-methoxyphenyl 2,4-dichlorobenzoate |
|
Vibrio |
VAS T6SS |
Preclinical (in vitro) |
Sun K, et al. 2014. Antimicrob Agents Chemother |
|
| 3-[1-[3-(1,3-benzothiazol-2-ylamino)-3-oxopropyl]triazol-4-yl]-6-hydroxy-2-phenyl-1-benzofuran-5-carboxylic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Huang Z, et al. 2010. Chem Biol Drug Des |
|
| 3-[1-[3-(9H-fluoren-9-ylamino)-3-oxopropyl]triazol-4-yl]-6-hydroxy-2-phenyl-1-benzofuran-5-carboxylic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Huang Z, et al. 2010. Chem Biol Drug Des |
|
| 3-[1-[3-(benzhydrylamino)-3-oxopropyl]triazol-4-yl]-6-hydroxy-2-phenyl-1-benzofuran-5-carboxylic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Huang Z, et al. 2010. Chem Biol Drug Des |
|
| 3-[1-[3-(benzylamino)-3-oxopropyl]triazol-4-yl]-6-hydroxy-2-phenyl-1-benzofuran-5-carboxylic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Huang Z, et al. 2010. Chem Biol Drug Des |
|
| | | |
